|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Searle_Pharmaceuticals
|
|
gptkbp:approves
|
gptkb:1987
gptkb:FDA
|
|
gptkbp:availability
|
prescription only
|
|
gptkbp:brand
|
gptkb:Prozac
|
|
gptkbp:class
|
gptkb:selective_serotonin_reuptake_inhibitor_(SSRI)
|
|
gptkbp:clinical_trial
|
depression treatment
OCD treatment
bulimia treatment
panic disorder treatment
|
|
gptkbp:contraindication
|
concurrent use of monoamine oxidase inhibitors
hypersensitivity to fluoxetine
|
|
gptkbp:discontinued
|
not applicable
|
|
gptkbp:dosage_form
|
60 mg daily
20 mg daily
40 mg daily
|
|
gptkbp:formulation
|
oral tablet
oral capsule
liquid solution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Fluoxetine
|
|
gptkbp:ingredients
|
C17 H18 F3 N
|
|
gptkbp:interacts_with
|
gptkb:thioridazine
gptkb:warfarin
MAO inhibitors
NSAI Ds
|
|
gptkbp:invention
|
gptkb:2001
|
|
gptkbp:is_available_on
|
generic drug
|
|
gptkbp:is_used_for
|
gptkb:historical_event
gptkb:bulimia_nervosa
obsessive-compulsive disorder
panic disorder
|
|
gptkbp:lifespan
|
1 to 4 days
|
|
gptkbp:marketed_as
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:related_to
|
gptkb:microprocessor
anxiety disorders
mental health treatment
mood disorders
serotonin
|
|
gptkbp:research_areas
|
mental health
pharmacology
psychiatry
|
|
gptkbp:safety_features
|
Category C (Pregnancy)
|
|
gptkbp:side_effect
|
anxiety
nausea
insomnia
dry mouth
sexual dysfunction
|
|
gptkbp:symptoms
|
dizziness
fatigue
sleep disturbances
irritability
mood swings
|
|
gptkbp:type_of
|
54910-89-3
|